United States · FDA National Drug Code directory
Chlorzoxazone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51862-339_ffd326e9-a80a-275a-e053-6394a90a213a
- Product NDC
- 51862-339
- Form
- TABLET
- Composition / generic term
- chlorzoxazone
- Labeler
- Mayne Pharma Commercial LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200731
- Source listing expiry
- 20261231
Source-listed ingredients
- CHLORZOXAZONE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (51862-339-01) · 51862-339-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →